Consensus Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Real-time Estimate Cboe BZX Other stock markets 11:51:15 2024-04-26 am EDT			5-day change	1st Jan Change
2.715 ^USD	+3.63%		+2.69%	+76.82%

Apr. 17	RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	MT
Apr. 10	Nuvation Bio Closes Acquisition of AnHeart Therapeutics	MT

Evolution of the average Target Price on Nuvation Bio Inc.

Price target over the last 5 years

History of analyst recommendation changes

d.QNN-Fyu64_S2QAfpJO9Gn2pd1oZ-9rrQh6qk3GMCjOM.Opk3bmfpr5f1J26dRtgP6xg8o_Awnc600O-QvStXwaxwnj8nfNSXwo8LVg~af35e9c1d0b84703112265325e0339ec

Analyst Recommendations on Nuvation Bio Inc.

RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	Apr. 17	MT
HC Wainwright Adjusts Nuvation Bio's Price Target to $8 From $5, Maintains Buy Rating	Mar. 28	MT
Jefferies Upgrades Nuvation Bio to Buy From Hold, Adjusts Price Target to $10 From $1.40	Mar. 27	MT
BTIG Upgrades Nuvation Bio to Buy From Neutral, Price Target is $5	Mar. 26	MT
H.C. Wainwright Raises Price Target on Nuvation Bio to $5 From $4.50, Maintains Buy Rating	Mar. 07	MT
RBC Cuts Price Target on Nuvation Bio to $4 From $5, Keeps Outperform, Speculative Risk	Nov. 06	MT
RBC Cuts Price Target on Nuvation Bio to $5 From $6, Keeps Outperform, Speculative Risk	23-05-05	MT
Jefferies Downgrades Nuvation Bio to Hold From Buy, Adjusts Price Target to $2 From $5	23-01-06	MT
HC Wainwright Adjusts Price Target on Nuvation Bio to $4.50 From $14, Reiterates Buy Rating	22-08-22	MT
BTIG Downgrades Nuvation Bio to Neutral From Buy	22-08-02	MT
BMO Capital Lowers Nuvation Bio to Market Perform From Outperform, Price Target to $2.50 From $8	22-08-02	MT
Wedbush Adjusts Price Target for Nuvation Bio to $5 From $17 on Discontinuation of NUV-422, Maintains Outperform Rating	22-08-01	MT
RBC Cuts Price Target on Nuvation Bio to $14 From $15, Maintains Outperform Rating, Speculative Risk Qualifier	22-05-11	MT
Wedbush Adjusts Nuvation Bio Price Target to $17 From $23, Maintains Outperform Rating	22-05-10	MT
HC Wainwright Starts Nuvation Bio at Buy With $14 Price Target	22-05-04	MT
BMO Capital Adjusts Nuvation Bio's Price Target to $12 From $17, Keeps Outperform Rating	22-03-22	MT
NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $23 From $21, Keeps Outperform Rating	21-08-13	MT
NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $21 From $20, Keeps Outperform Rating	21-05-18	MT
NUVATION BIO : RBC Capital Starts Nuvation Bio at Outperform with $15 Price Target	21-04-06	MT
NUVATION BIO : Jefferies Starts Nuvation Bio at Buy With $20 Price Target	21-03-08	MT
NUVATION BIO : BTIG Initiates Coverage on Nuvation Bio With Buy Rating, Sets Price Target at $16	21-03-08	MT
NUVATION BIO : Cowen Starts Nuvation Bio at Outperform	21-03-08	MT
NUVATION BIO : BMO Capital Starts Nuvation Bio at Outperform With $16 Price Target	21-03-08	MT
NUVATION BIO : Wedbush Starts Nuvation Bio at Outperform With $20 Price Target	21-03-08	MT